Atypical Cellular Disorders
Kenneth McClain, MD, PhD; Yasodha Natkunam, MD, PhD; Steven H. Swerdlow, MD

Central Nervous System Disease in LCH
Nicole Grois, MD
Note: The CNS LCH protocol closed in September 2002.

Cognitive Outcome of Long-Term Survivors of Multisystem Langerhans Cell Histiocytosis
Vasanta Nanduri, MD; Leasha Lillywhite; Claire Chapman, et. al.

Differential In Situ Cytokine Profiles of Langerhans-Like Cells and T Cells in Langerhans Cell Histiocytosis: Abundant Expression of Cytokines Relevant to Disease and Treatment
R. Maarten Egeler, MD, PhD; Blaise E. Favara, MD; Marjan van Meurs, MD; et. al.

Histiocytosis
Cameron Tebbi, MD; Robert Arceci, MD, PhD; Thomas Loew, MD

Historical Review: The Langerhans Cell Histiocysosis X Files Revealed
Arty Coppes-Zantinga; R. Maarten Egeler, MD, PhD

LCH of the Skin
Sheila Weitzman, MB, ChB

LCH: The Symptoms, Diagnosis and Treatment
R. Egeler, MD, PhD

New Treatment Approaches for Patients with LCH
Robert J. Arceci, MD, PhD

Neuropsychological Problems in Langerhans Cell Histiocytosis
Vasanta Nanduri, MD; Edda Unger, MD; Nicole Grois, MD

Pathologic Diagnosis of the Histiocytic Disorders of Childhood
Ronald Jaffe, MB,BCh

Pulmonary LCH
Emanuela De Juli, MD; Michaela Allen, MD; Maurizio Aricò, MD

The Histiocytoses
Ronald Jaffe, MB, BCh
Per publisher's request, this is a read-only article and cannot be printed

The Importance of Clinical Trials in the Fight Against Histiocytosis
Milen Minkov, MD; James Whitlock, MD

Vaccination of Immunocompromised Children
Kenneth McClain, MD, PhD

Click here for articles on LCH in Adults

Click here for articles on Hemophagocytic Syndromes